U.S. Endoscope Repair Market

Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "U.S. Endoscope Repair Market Report: By Type, Service Provider - Size, Share Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. In 2021, the U.S. endoscope repair market was valued at $405.6 million, and it is set to reach $990.7 million by 2030, growing at a compound annual growth rate of 10.4% during 2021-2030.

The rise in the acceptance of equipment insurance, the existence of stalwarts, and the surge in the incidence of malignant gastrointestinal, respiratory, and colorectal diseases are some of the factors propelling the market growth. Within the U.S. endoscope repair market, the flexible category held the major share, of around 70%, in 2021. As flexible endoscopes comprise readily movable tubes, are light in weight, and can be attached to components at the top that can scrape and scratch the tissues under examination, they are used in minor operating procedures.

Flexible endoscopes are also more comfortable for patients and provide a greater vision for endoscopists.

The cost of the maintenance of medical devices is high, which propels the demand for their insurance. Several firms in the country offer medical device insurance to shield equipment users from financial losses in the event of equipment failures, such as Medical Equipment Repair Associates, ProTek Insurance, and CAN Financial Corporation. To keep ahead of their competition, major players in the U.S. endoscope repair market have engaged in mergers. Some of these players are Endoscopy Repair Specialist Inc., HMB Endoscopy Products, Endoscopy Support Services Inc., STERIS Instrument Management Services Inc., Associated Endoscopy Inc., Medical Optics, Stryker Corporation, Total Scope Inc., J2S Medical, and Agiliti Inc.

Key Findings of U.S. Endoscope Repair Market Report

Mobile Instrument Service & Repair Inc., a company that specializes in servicing rigid and flexible endoscopes, powered surgical equipment, laparoscopic and general handheld instruments, case carts, processing systems, video cameras, and rolling stock sterilizers, was acquired by Agiliti Inc. in February 2020.

In December 2018, Agiliti Holdco Inc. and Federal Street Acquisition Corp. agreed to alter and restate their merger agreement, lowering the total price paid to Agiliti Holdco Inc.'s selling equity investors from roughly $1.58 billion to $1.44 billion.

In the past, Texas dominated the U.S. endoscope repair market. Furthermore, the state market is predicted to grow at a significant CAGR, mostly due to the state's large elderly population, as well as the high cancer prevalence.

Moreover, the Employees Retirement System, Teacher Retirement System, Texas Department of Aging and Disability Services, and Texas Department of State Health Services account for over 83% of Texas' yearly healthcare budget, thus making endoscopies and other treatments accessible to the masses.

OEMs hold a significant revenue share in the market owing to their ability to provide quick, dependable, and superior services than ISOs. Furthermore, OEM components can be employed to substitute original parts, as they have similar performance.

In the coming years, the ISOs category is predicted to grow at a CAGR of over 10%. This can be mostly due to the advantages offered by ISOs, such as lower costs and increased flexibility in maintaining and repairing endoscopic equipment from various OEMs.

Key Topics Covered: Chapter 1. Research Background Chapter 2. Research Methodology Chapter 3. Executive Summary Chapter 4. Market Indicators 4.1 Healthcare Spending 4.2 Geriatric Population 4.3 Prevalence of Obesity Chapter 5. Definition of Market Segments 5.1 By Type 5.1.1 Flexible 5.1.1.1 Upper gastrointestinal endoscopes 5.1.1.2 Colonoscopes 5.1.1.3 Bronchoscopes 5.1.1.4 Sigmoidoscopes 5.1.1.5 Laryngoscopes 5.1.1.6 Duodenoscopes 5.1.1.7 Nasopharyngoscopes 5.1.1.8 Rhinoscopes 5.1.1.9 Others 5.1.2 Rigid 5.1.2.1 Laparoscopes 5.1.2.2 Ureteroscopes 5.1.2.3 Gynecology endoscopes 5.1.2.4 Arthroscopes 5.1.2.5 Cystoscopes 5.1.2.6 Neuroendoscopes 5.1.2.7 Others 5.2 By Service Provider 5.2.1 ISOs 5.2.2 OEMs Chapter 6. Industry Outlook 6.1 Market Dynamics 6.1.1 Trends 6.1.1.1 Increasing adoption of comprehensive contracts 6.1.1.2 Rising adoption of equipment insurance 6.1.2 Drivers 6.1.2.1 Advancements in medical device industry 6.1.2.2 Shift toward minimally invasive procedures 6.1.3 Impact Analysis of Drivers on Market Forecast 6.1.4 Restraints 6.1.4.1 High maintenance costs 6.1.5 Impact Analysis of Restraints on Market Forecast 6.2 Impact of COVID-19 6.3 Porter's Five Forces Analysis Chapter 7. Policy and Regulatory Landscape Chapter 8. U.S. Market Size and Forecast 8.1 Overview 8.2 Market Revenue, by Type (2015-2030) 8.2.1 Flexible Endoscope Market Revenue, by Type (2015-2030) 8.2.2 Rigid Endoscope Market Revenue, by Type (2015-2030) 8.3 Market Revenue, by Service Provider (2015-2030) 8.4 Market Revenue, by State (2015-2030) Chapter 9. Competitive Landscape 9.1 List of Market Players 9.2 Closest Segments and Market Revenue Derivation 9.3 Recent Strategic Developments of Key Players 9.3.1 Mergers and Acquisitions 9.3.2 Other Developments Chapter 10. Company Profiles 10.1 Business Overview 10.2 Product and Service Offerings

For more information about this report visit https://www.researchandmarkets.com/r/u2b3w3

U.S. Endoscope Repair Market

Yahoo Finance Live anchors discuss stock performance for FedEx.

Mizuho analyst Vijay Rakesh just lowered his price target on Nvidia, but if he's right it's a good buy from here.

FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.

There was a sell-off in cardboard packaging stocks this morning, with shares of International Paper (NYSE: IP) down 9.4% at 10:30 a.m. ET on Friday, Packaging Corporation of America (NYSE: PKG) shares down 9.7%, and the stock of WestRock (NYSE: WRK) down 9.8%. Shares of FedEx (NYSE: FDX) plunged more than 22% this morning after the company issued an earnings warning predicated on softening global volume. The volume FedEx referred to was the number of packages wrapped in cardboard and shipped to customers.

Amazon's founder and executive chairman was the world's richest man for several years before falling to second place.

As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.

Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.

Electric vehicle (EV) stocks have gotten a lot of attention over the last few years as production has increased and multiple companies have come public, but that doesn't mean all EV stocks are good investments. Companies still have to make money building and selling vehicles, which has historically been the hardest part of the auto business. Given the current trends, I think General Motors (NYSE: GM) is the one EV stock to buy hand over fist, while ChargePoint (NYSE: CHPT) and Canoo (NASDAQ: GOEV) have some serious red flags.

These highly profitable companies offer sustainable competitive advantages that make them no-brainer buys.

Warren Buffett's Berkshire Hathaway is about to lose one of its higher-yielding dividend stocks. STORE Capital (NYSE: STOR), a real estate investment trust (REIT) with a high dividend yield, has agreed to be taken private by GIC and Oak Street. Because of that, Berkshire and other investors relying on STORE to supply them with passive income will need to find a replacement.

Intel (INTC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Warren Buffett's Berkshire Hathaway bought a bunch of stocks during the second quarter. Notable names included Apple (NASDAQ: AAPL), Activision Blizzard (NASDAQ: ATVI), Occidental Petroleum (NYSE: OXY), and Chevron (NYSE: CVX). Buffett seems to be most bullish on Apple and Occidental Petroleum.

Yahoo Finance anchors break down how markets are trading at the end of the week.

Recent developments suggest business trends are getting worse---not better, meaning there could be more downside ahead.

Wall Street is on a roller coaster again, as investors try to navigate the path between high inflation and the Fed’s aggressive interest rate hikes. What we know for certain is that the S&P 500 is down 18% year-to-date, and the NASDAQ is down 26%. At least one investing expert, however, is getting on his soapbox to encourage investors to buy now, while prices are low. This is the view of Shark Tank investor Kevin O’Leary. The venture capitalist makes a case for investors to take advantage of vol

Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novartis (NVS), Merck (MRK) and AstraZeneca (AZN) are worth retaining in your portfolio.

Income investors are always on the hunt for good stocks that for one reason or another have recently been out of favor, creating a scenario for a higher dividend yield along with possible future appreciation as the stock bounces back. Buying a stock on a decline sometimes involves a bit of courage, but the ability to lock in long-term higher yields makes the decision easier for most investors. At the moment, Medical Properties Trust Inc. (NYSE: MPW), a Birmingham, Alabama-based real estate inves

FedEx turned in poor earnings results and slashed its revenue forecast on Thursday as the company’s CEO warned that a “worldwide recession” is likely coming.

RSM Chief Economist Joe Brusuelas joins Yahoo Finance Live to discuss FedEx's economic warnings, the U.S. economy compared to foreign markets, mortgage rates in housing, and the market outlook amid inflation.

Broadcom Inc. (AVGO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.